Healio11h
Semaglutide may raise risk for form of optic neuropathy in adults with type 2 diabetes
Adults with type 2 diabetes may have a higher risk for developing nonarteritic anterior ischemic optic neuropathy while using ...
ophthalmologytimes11h
Efficacy and safety findings for lenadogene nolparvovec (Lumevoq) from REFLECT Phase III trial
Patients who underwent bilateral treatment experienced a higher rate of clinically relevant recovery, the authors reported.
Medpage Today on MSN23h
Semaglutide Tied to Small Risk of Potentially Blinding Eye Condition
The use of semaglutide (Ozempic) was tied to a small risk of nonarteritic anterior ischemic optic neuropathy (NAION) in ...